127 related articles for article (PubMed ID: 12066223)
1. Sarcoma and thyroid disorders: a common etiology?
Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
[TBL] [Abstract][Full Text] [Related]
2. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
4. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
5. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
6. The v-erbA oncogene (review).
Thormeyer D; Baniahmad A
Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
[TBL] [Abstract][Full Text] [Related]
7. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
8. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
9. An identical effect mediated by thyroid deficiency or oncogene v-erbA in the chick embryo.
Bachnou N; Saule S; Dieterlen-Lievre F
Int J Dev Biol; 1996 Apr; 40(2):491-7. PubMed ID: 8793620
[TBL] [Abstract][Full Text] [Related]
10. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
[TBL] [Abstract][Full Text] [Related]
11. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
Nagl SB; Bunn CF; Allison LA
J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
13. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC
Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor, v-ErbA, and chromatin.
Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ferritin mRNA translation in primary erythroblasts: exogenous c-Kit plus EpoR signaling mimics v-ErbA oncoprotein activity.
Mikulits W; Schranzhofer M; Deiner EM; Beug H; Müllner EW
Biochem Biophys Res Commun; 2000 Aug; 275(2):292-4. PubMed ID: 10964660
[TBL] [Abstract][Full Text] [Related]
16. An endogenous signal triggering erythroid differentiation: identification as thyroid hormone.
Dinnen RD; White SR; Elsayed S; Yeh YI; Ebisuzaki K
Cell Growth Differ; 1994 Aug; 5(8):855-61. PubMed ID: 7986750
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor mutations in cancer.
Cheng SY
Mol Cell Endocrinol; 2003 Dec; 213(1):23-30. PubMed ID: 15062571
[TBL] [Abstract][Full Text] [Related]
18. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the DNA binding specificity and function of v-ErbA and thyroid hormone receptor alpha 1.
Subauste JS; Koenig RJ
J Biol Chem; 1995 Apr; 270(14):7957-62. PubMed ID: 7713893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
